Table 4:

Summary statistics of potential predictors of late mortality and univariate Cox regression results

Late mortality
HR (95% CI)P-value
Yes (n = 16)No (n = 176)
Year of surgery, n (%)2001–20192 (12.5)108 (61.4)10.19
1991–20007 (43.7)38 (21.6)4.37 (0.87–22.03)
1978–19907 (43.7)30 (17.1)3.87 (0.73–20.38)

Age at surgery (months)

 Mean (SD)

 Median (IQR)

91.9 (93.3)

36 (26.5–150.5)

59.3 (64.5)

43.5 (30.5–63.5)

1.00 (1.00–1.01)

0.057
Systemic RV, n (%)4 (25.0)65 (36.9)0.75 (0.242.35)0.62
Staged Fontan, n (%)10 (62.5)136 (78.6)0.99 (0.342.87)0.99
Fenestration, n (%)5 (31.2)123 (70.3)0.43 (0.141.33)0.14
Heart failure, n (%)5 (83.3)11 (7.9)28.69 (3.27–251.62)0.002
Liver disease, n (%)3 (50.0)6 (3.7)8.01 (1.42–45.27)0.019
Pulmonary hypertension, n (%)2 (33.3)13 (9.3)6.47 (1.16–36.16)0.030
BVF, n (%)3 (18.7)38 (21.6)1.25 (0.354.46)0.72
Late mortality
HR (95% CI)P-value
Yes (n = 16)No (n = 176)
Year of surgery, n (%)2001–20192 (12.5)108 (61.4)10.19
1991–20007 (43.7)38 (21.6)4.37 (0.87–22.03)
1978–19907 (43.7)30 (17.1)3.87 (0.73–20.38)

Age at surgery (months)

 Mean (SD)

 Median (IQR)

91.9 (93.3)

36 (26.5–150.5)

59.3 (64.5)

43.5 (30.5–63.5)

1.00 (1.00–1.01)

0.057
Systemic RV, n (%)4 (25.0)65 (36.9)0.75 (0.242.35)0.62
Staged Fontan, n (%)10 (62.5)136 (78.6)0.99 (0.342.87)0.99
Fenestration, n (%)5 (31.2)123 (70.3)0.43 (0.141.33)0.14
Heart failure, n (%)5 (83.3)11 (7.9)28.69 (3.27–251.62)0.002
Liver disease, n (%)3 (50.0)6 (3.7)8.01 (1.42–45.27)0.019
Pulmonary hypertension, n (%)2 (33.3)13 (9.3)6.47 (1.16–36.16)0.030
BVF, n (%)3 (18.7)38 (21.6)1.25 (0.354.46)0.72

BVF: biventricular Fontan; CI: confidence interval; HR: hazard ratio; IQR: interquartile range; RV: right ventricle; SD: standard deviation.

Boldface are those values which are statistically significant.

Table 4:

Summary statistics of potential predictors of late mortality and univariate Cox regression results

Late mortality
HR (95% CI)P-value
Yes (n = 16)No (n = 176)
Year of surgery, n (%)2001–20192 (12.5)108 (61.4)10.19
1991–20007 (43.7)38 (21.6)4.37 (0.87–22.03)
1978–19907 (43.7)30 (17.1)3.87 (0.73–20.38)

Age at surgery (months)

 Mean (SD)

 Median (IQR)

91.9 (93.3)

36 (26.5–150.5)

59.3 (64.5)

43.5 (30.5–63.5)

1.00 (1.00–1.01)

0.057
Systemic RV, n (%)4 (25.0)65 (36.9)0.75 (0.242.35)0.62
Staged Fontan, n (%)10 (62.5)136 (78.6)0.99 (0.342.87)0.99
Fenestration, n (%)5 (31.2)123 (70.3)0.43 (0.141.33)0.14
Heart failure, n (%)5 (83.3)11 (7.9)28.69 (3.27–251.62)0.002
Liver disease, n (%)3 (50.0)6 (3.7)8.01 (1.42–45.27)0.019
Pulmonary hypertension, n (%)2 (33.3)13 (9.3)6.47 (1.16–36.16)0.030
BVF, n (%)3 (18.7)38 (21.6)1.25 (0.354.46)0.72
Late mortality
HR (95% CI)P-value
Yes (n = 16)No (n = 176)
Year of surgery, n (%)2001–20192 (12.5)108 (61.4)10.19
1991–20007 (43.7)38 (21.6)4.37 (0.87–22.03)
1978–19907 (43.7)30 (17.1)3.87 (0.73–20.38)

Age at surgery (months)

 Mean (SD)

 Median (IQR)

91.9 (93.3)

36 (26.5–150.5)

59.3 (64.5)

43.5 (30.5–63.5)

1.00 (1.00–1.01)

0.057
Systemic RV, n (%)4 (25.0)65 (36.9)0.75 (0.242.35)0.62
Staged Fontan, n (%)10 (62.5)136 (78.6)0.99 (0.342.87)0.99
Fenestration, n (%)5 (31.2)123 (70.3)0.43 (0.141.33)0.14
Heart failure, n (%)5 (83.3)11 (7.9)28.69 (3.27–251.62)0.002
Liver disease, n (%)3 (50.0)6 (3.7)8.01 (1.42–45.27)0.019
Pulmonary hypertension, n (%)2 (33.3)13 (9.3)6.47 (1.16–36.16)0.030
BVF, n (%)3 (18.7)38 (21.6)1.25 (0.354.46)0.72

BVF: biventricular Fontan; CI: confidence interval; HR: hazard ratio; IQR: interquartile range; RV: right ventricle; SD: standard deviation.

Boldface are those values which are statistically significant.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close